Able View Global Inc. (NASDAQ: ABLV) received a formal notice from the Nasdaq Listing Qualifications Department on December 4 2025, and the company disclosed the deficiency to investors on December 9 2025. The letter states that the company’s ordinary shares failed to maintain the required minimum bid price of $1.00 from October 22 through December 3 2025, creating a compliance deficiency under Nasdaq Listing Rule 5550(a)(2).
Under the rule, ABLV has 180 calendar days—until June 2 2026—to restore compliance. During this period the shares will continue to trade on the Nasdaq Capital Market, but the company must achieve a closing bid price of at least $1.00 for ten consecutive business days to avoid further regulatory action. If the company cannot meet this threshold, it may be eligible for additional time or, if it remains non‑compliant, could face delisting proceedings. The notice also warns that a closing bid price of $0.10 or less for ten consecutive trading days would trigger a staff delisting determination.
Able View’s financial performance has been a contributing factor to the bid‑price shortfall. For the full year 2024 the company reported revenue of $128.93 million, down 13.5% from $149 million in 2023, and a net loss of $7.42 million versus a net income of $9.75 million a year earlier. In the six months ended June 30 2025, the company posted a net income of $3.42 million, a turnaround from a $6.34 million loss in the same period of 2024. The decline in revenue and the swing to a loss in 2024 reflect weaker demand in key beauty‑brand management segments and higher operating costs, which have pressured the share price below the Nasdaq minimum bid threshold.
Management has acknowledged the deficiency and said it is monitoring the bid price closely. The company is exploring options to address the shortfall, including potential capital raises and strategic initiatives aimed at boosting share demand. While no specific capital‑raising plan has been announced, the company’s recent improvement in profitability suggests it may be able to generate the cash flow needed to support a share‑price recovery. The company’s board has also indicated that it will consider additional measures, such as share‑price‑supporting actions or a restructuring of its capital structure, if the bid price remains below $1.00.
The Nasdaq notice has already influenced market sentiment. Following the disclosure, analysts have expressed concern about the company’s liquidity and long‑term viability. The company’s market capitalization was approximately $38.4 million as of December 9 2025, and the stock’s recent volatility has heightened investor scrutiny. Analysts have highlighted the risk that a prolonged bid‑price deficiency could lead to delisting, which would severely limit the company’s ability to raise capital and could depress the share price further. The company’s management remains optimistic that the 180‑day window will provide sufficient time to implement corrective measures and restore compliance.
The deficiency notice underscores the importance of maintaining Nasdaq listing standards. For investors, the key risk is the potential loss of trading access and liquidity if the company fails to meet the bid‑price requirement by June 2 2026. Conversely, the company’s recent turnaround in profitability and its willingness to pursue capital‑raising options may mitigate some of the downside risk. Investors should monitor the company’s bid‑price trajectory and any announced capital‑raising or restructuring plans as the compliance deadline approaches.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.